223 related articles for article (PubMed ID: 14536066)
1. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity.
Rangwala SM; Rhoades B; Shapiro JS; Rich AS; Kim JK; Shulman GI; Kaestner KH; Lazar MA
Dev Cell; 2003 Oct; 5(4):657-63. PubMed ID: 14536066
[TBL] [Abstract][Full Text] [Related]
2. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
[TBL] [Abstract][Full Text] [Related]
3. [The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism].
Kamon J; Yamauchi T; Terauchi Y; Kubota N; Kadowaki T
Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):294-300. PubMed ID: 14501164
[TBL] [Abstract][Full Text] [Related]
4. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
Tsai YS; Kim HJ; Takahashi N; Kim HS; Hagaman JR; Kim JK; Maeda N
J Clin Invest; 2004 Jul; 114(2):240-9. PubMed ID: 15254591
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
Norris AW; Chen L; Fisher SJ; Szanto I; Ristow M; Jozsi AC; Hirshman MF; Rosen ED; Goodyear LJ; Gonzalez FJ; Spiegelman BM; Kahn CR
J Clin Invest; 2003 Aug; 112(4):608-18. PubMed ID: 12925701
[TBL] [Abstract][Full Text] [Related]
6. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk TH; Grefhorst A; Abdelkarim M; Caron S; Torpier G; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B
J Biol Chem; 2006 Apr; 281(16):11039-49. PubMed ID: 16446356
[TBL] [Abstract][Full Text] [Related]
7. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
He W; Barak Y; Hevener A; Olson P; Liao D; Le J; Nelson M; Ong E; Olefsky JM; Evans RM
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15712-7. PubMed ID: 14660788
[TBL] [Abstract][Full Text] [Related]
8. C333H ameliorated insulin resistance through selectively modulating peroxisome proliferator-activated receptor γ in brown adipose tissue of db/db mice.
Zhang N; Chen W; Zhou X; Zhou X; Xie X; Meng A; Li S; Wang L
Biol Pharm Bull; 2013; 36(6):980-7. PubMed ID: 23563593
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
[TBL] [Abstract][Full Text] [Related]
10. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy.
Catalano PM; Nizielski SE; Shao J; Preston L; Qiao L; Friedman JE
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E522-33. PubMed ID: 11832353
[TBL] [Abstract][Full Text] [Related]
11. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
[TBL] [Abstract][Full Text] [Related]
12. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
Takasawa K; Kubota N; Terauchi Y; Kadowaki T
Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
[TBL] [Abstract][Full Text] [Related]
13. Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance.
Gui Y; Silha JV; Mishra S; Murphy LJ
Can J Physiol Pharmacol; 2003 Oct; 81(10):979-85. PubMed ID: 14608416
[TBL] [Abstract][Full Text] [Related]
14. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance.
Kadowaki T; Hara K; Kubota N; Tobe K; Terauchi Y; Yamauchi T; Eto K; Kadowaki H; Noda M; Hagura R; Akanuma Y
J Diabetes Complications; 2002; 16(1):41-5. PubMed ID: 11872365
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance.
Amin RH; Mathews ST; Camp HS; Ding L; Leff T
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E28-37. PubMed ID: 19843873
[TBL] [Abstract][Full Text] [Related]
16. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
Gavrilova O; Haluzik M; Matsusue K; Cutson JJ; Johnson L; Dietz KR; Nicol CJ; Vinson C; Gonzalez FJ; Reitman ML
J Biol Chem; 2003 Sep; 278(36):34268-76. PubMed ID: 12805374
[TBL] [Abstract][Full Text] [Related]
17. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.
Combs TP; Pajvani UB; Berg AH; Lin Y; Jelicks LA; Laplante M; Nawrocki AR; Rajala MW; Parlow AF; Cheeseboro L; Ding YY; Russell RG; Lindemann D; Hartley A; Baker GR; Obici S; Deshaies Y; Ludgate M; Rossetti L; Scherer PE
Endocrinology; 2004 Jan; 145(1):367-83. PubMed ID: 14576179
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
19. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression.
Ryder JW; Portocarrero CP; Song XM; Cui L; Yu M; Combatsiaris T; Galuska D; Bauman DE; Barbano DM; Charron MJ; Zierath JR; Houseknecht KL
Diabetes; 2001 May; 50(5):1149-57. PubMed ID: 11334420
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.
Masugi J; Tamori Y; Mori H; Koike T; Kasuga M
Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
